The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer

The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer

<p>Muscle invasive bladder cancer (MIBC) has a poor prognosis. Currently, therapy consists of radical radiotherapy or cystectomy with or without chemotherapy. The average age of patients with MIBC is high and older patients are less able to tolerate surgery or chemoradiation due to their impai...

Deskribapen osoa

Xehetasun bibliografikoak
Egile nagusia:	Groselj, B
Beste egile batzuk:	Kiltie, A
Formatua:	Thesis
Hizkuntza:	English
Argitaratua:	2014
Gaiak:	Oncology Biology

Antzeko izenburuak

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
nork: Groselj, B, et al.
Argitaratua: (2013)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
nork: Groselj, B, et al.
Argitaratua: (2013)

Histone deacetylase inhibitors as radiosensitisers: Effects on DNA damage signalling and repair
nork: Groselj, B, et al.
Argitaratua: (2013)

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair.
nork: Groselj, B, et al.
Argitaratua: (2013)

Histone Deacetylases and Their Potential as Targets to Enhance Tumour Radiosensitisation
nork: Jennifer Antrobus, et al.
Argitaratua: (2022-03-01)

The histone deacetylase inhibitor romidepsin spares normal tissues while acting as an effective radiosensitiser in bladder tumours in vivo
nork: Paillas, S, et al.
Argitaratua: (2020)

Radiosensitisation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity
nork: Groselj, B, et al.
Argitaratua: (2017)

Identification of novel strategies to radiosensitise tumour cells
nork: Anbalagan, S
Argitaratua: (2014)

The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines.
nork: Jan M Klein, et al.
Argitaratua: (2013-01-01)

Internalising radioimmunoconjugates to target KRas cancer cells for simultaneous radio-ligand therapy and radiosensitisation
nork: Lourenço, J
Argitaratua: (2024)

The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression
nork: Lin Xiao, et al.
Argitaratua: (2022-05-01)

The emerging role of histone deacetylase (HDAC) inhibitors in urological cancers.
nork: Sharma, N, et al.
Argitaratua: (2013)

Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation
nork: Anne Catherine Harttrampf, et al.
Argitaratua: (2021-07-01)

Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.
nork: Tao Yan-Fang, et al.
Argitaratua: (2015-01-01)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
nork: Monica Phimmachanh, et al.
Argitaratua: (2020-10-01)

The HDAC Inhibitor Panobinostat Promotes Expression of Delta 133p53 Variants in TP53 Wild-type Bladder Cancer Cells
nork: Groselj, B, et al.
Argitaratua: (2012)

Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma
nork: AGM Mostofa, et al.
Argitaratua: (2021-12-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
nork: Masumeh Sanaei, et al.
Argitaratua: (2019-01-01)

Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
nork: Martina Korfei, et al.
Argitaratua: (2018-01-01)

Acetylation and Histone Deacetylase Inhibitors in Cancer
nork: Madeleine S. Q. Kortenhorst, et al.
Argitaratua: (2006-01-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
nork: Kelly N. Hassell
Argitaratua: (2019-11-01)

The Pan-Deacetylase Inhibitor Panobinostat Inhibits Growth of Hepatocellular Carcinoma Models by Alternative Pathways of Apoptosis
nork: Pietro Di Fazio, et al.
Argitaratua: (2010-01-01)

Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines.
nork: Yukiko Hazama, et al.
Argitaratua: (2022-01-01)

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
nork: Guo Li, et al.
Argitaratua: (2020-09-01)

HBI-8000, HUYABIO Lead Clinical Program, Is a Selective Histone Deacetylase Inhibitor With Therapeutic Benefits in Leukemia and in Solid Tumors
nork: Farbod Shojaei, et al.
Argitaratua: (2022-01-01)

SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A
nork: Ruicai Gu, et al.
Argitaratua: (2023-10-01)

Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines
nork: Zopf Steffen, et al.
Argitaratua: (2012-09-01)

Fluid-electrolyte homeostasis requires histone deacetylase function
nork: Kelly A. Hyndman, et al.
Argitaratua: (2020-08-01)

Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
nork: Bittner, M
Argitaratua: (2017)

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
nork: Fengyi Guo, et al.
Argitaratua: (2022-11-01)

Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
nork: Bin Tu, et al.
Argitaratua: (2020-06-01)

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
nork: Danqi Chen, et al.
Argitaratua: (2016-01-01)

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo
nork: Liebes Leonard, et al.
Argitaratua: (2007-10-01)

Histone deacetylase inhibitors in multiple myeloma
nork: Sarah Deleu, et al.
Argitaratua: (2009-06-01)

Clinical Toxicities of Histone Deacetylase Inhibitors
nork: Richard L. Piekarz, et al.
Argitaratua: (2010-08-01)

The application of histone deacetylases inhibitors in glioblastoma
nork: Rui Chen, et al.
Argitaratua: (2020-07-01)

Antidepressant Actions of Histone Deacetylase Inhibitors
nork: Haggarty, Stephen J., et al.
Argitaratua: (2010)

Medicinal chemistry of histone deacetylase inhibitors
nork: Ružić Dušan, et al.
Argitaratua: (2021-01-01)

Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype
nork: Felix Orben, et al.
Argitaratua: (2022-05-01)

Dietary fibre manipulation as a potential endogenous mechanism of radiosensitisation in bladder cancer
nork: Then, CK
Argitaratua: (2022)